BioNTech SE - ADR

NASDAQ:BNTX  
163.12
-4.75 (-2.83%)
Other Pre-Announcement

BioNtech SE Reports Q4 Revenue Of 5.5 Bln Euros

Published: 03/30/2022 10:19 GMT
BioNTech SE - ADR (BNTX) - Expect to Authorize a Share Repurchase Program of Up to $1.5 Billion Over Next Two Years.
Will Propose a Special Cash Dividend of EUR 2.00 per Share, Pending Approval at Annual General Meeting.
Reiterate Biontech Covid-19 2022 Vaccine Revenue Guidance of EUR 13 Billion to EUR 17 Billion.
Sees 2022 Capital Expenditures EUR 450 Million - EUR 550 Million.
Qtrly Diluted Profit per Share €12.18.
Q4 Earnings per Share View EUR 7.44, Revenue View EUR 3.92 Billion -- Refinitiv Ibes Data (analyst estimates).